Showing results (41-50 of 67) with videos related to
Sort By:
Pageof 7
The Journal of Clinical Psychiatry|January 2, 2007
Prediction of remission as a combination of symptomatic and functional remission and adequate subjective well-being in 2960 patients with schizophreniaMartin Lambert, Benno G Schimmelmann, Dieter Naber, et al.Pharmaceutical Statistics|January 11, 2020
What matters most? Different stakeholder perspectives on estimands for an invented case study in COPDOliver N Keene, Stephen Ruberg, Alexander Schacht, et al.The Clinical Journal of Pain|December 4, 2013
Effectiveness of duloxetine compared with pregabalin and gabapentin in diabetic peripheral neuropathic pain: results from a German observational studyMichael Happich, Edith Schneider, Frank G Boess, et al.Journal of Psychiatric Research|August 28, 2007
Patterns of physician and patient rated quality of life during antipsychotic treatment in outpatients with schizophreniaPeter M Wehmeier, Michael Kluge, Alexander Schacht, et al.Child and Adolescent Psychiatry and Mental Health|August 26, 2009
Atomoxetine treatment and ADHD-related difficulties as assessed by adolescent patients, their parents and physiciansRalf W Dittmann, Peter M Wehmeier, Alexander Schacht, et al.Journal of Child and Adolescent Psychopharmacology|March 5, 2008
Effectiveness of atomoxetine and quality of life in children with attention-deficit/hyperactivity disorder as perceived by patients, parents, and physicians in an open-label studyPeter M Wehmeier, Ralf W Dittmann, Alexander Schacht, et al.Child and Adolescent Psychiatry and Mental Health|May 30, 2008
Emotional well-being in children and adolescents treated with atomoxetine for attention-deficit/hyperactivity disorder: findings from a patient, parent and physician perspective using items from the pediatric adverse event rating scale (PAERS)Peter M Wehmeier, Alexander Schacht, Martin Lehmann, et al.Journal of Child and Adolescent Psychopharmacology|April 15, 2011
Atomoxetine versus placebo in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: a double-blind, randomized, multicenter trial in GermanyRalf W Dittmann, Alexander Schacht, Karin Helsberg, et al.The Primary Care Companion for CNS Disorders|February 11, 2015
Impact of pretreatment with antidepressants on the efficacy of duloxetine in terms of mood symptoms and functioning: an analysis of 15 pooled major depressive disorder studiesBruno R Barros, Alexander Schacht, Michael Happich, et al.Pain|June 5, 2013
Duloxetine and pregabalin: high-dose monotherapy or their combination? The "COMBO-DN study"--a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic painSolomon Tesfaye, Stefan Wilhelm, Alberto Lledo, et al.Pageof 7